The Hair Loss Encyclopedia

Search

for
Search:

Glossary6-Mercaptopurine

chemotherapy drug that inhibits cancer cell growth

6-Mercaptopurine (6-MP) is a chemotherapy medication used primarily to treat certain types of cancer, such as acute lymphoblastic leukemia (ALL). It works by interfering with the growth of cancer cells, which are then destroyed by the body. 6-MP is also used in the treatment of some autoimmune diseases due to its immunosuppressive properties.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 118 results

research Concomitant Management of Alopecia Universalis and Ulcerative Colitis With Upadacitinib

2 citations , September 2024 in “Internal Medicine Journal”

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Review Article: Dermatological Complications of Immunosuppressive and Anti-TNF Therapy in Inflammatory Bowel Disease

research Review Article: Dermatological Complications of Immunosuppressive and Anti-TNF Therapy in Inflammatory Bowel Disease

60 citations , September 2013 in “Alimentary Pharmacology & Therapeutics”

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The Effect of Active Hexose Correlated Compound in Modulating Cytosine Arabinoside-Induced Hair Loss, and 6-Mercaptopurine- and Methotrexate-Induced Liver Injury in Rodents

research The Effect of Active Hexose Correlated Compound in Modulating Cytosine Arabinoside-Induced Hair Loss, and 6-Mercaptopurine- and Methotrexate-Induced Liver Injury in Rodents

14 citations , August 2009 in “Cancer epidemiology”

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

research Methotrexate for Maintenance of Remission in Ulcerative Colitis

51 citations , August 2015 in “Cochrane library”

Methotrexate is not proven to maintain remission in ulcerative colitis.

Cutaneous Crohn's Disease Treated with Infliximab and 4 Years of Follow-Up

research Cutaneous Crohn's Disease Treated with Infliximab and 4 Years of Follow-Up

9 citations , June 2013 in “Australasian Journal of Dermatology”

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

View more "mercaptopurine" in research →

Community Join

0 / 0 results

— no results